You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oesophagogastric adenocarcinoma,

Showing 1 - 25 of 1,907
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Oct 6, 2021

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in China (Apatinib 250mg, Camrelizumab, S-1, Oxaliplatin)

Recruiting
  • Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Apatinib 250mg
  • +3 more
  • Baoding, China
  • +22 more
Jul 11, 2022

Adenocarcinoma of the Oesophagus, Adenocarcinoma of the Oesophago-gastric Junction, Oesophageal Tumours Trial in Worldwide

Completed
  • Adenocarcinoma of the Oesophagus
  • +4 more
  • Blegdamsvej 9, Denmark
  • +28 more
Sep 29, 2022

Depending on Surgical Treatment in Adenocarcinomas of

Completed
Has Results
  • Esophageal Carcinoma
    • (no location specified)
    Dec 9, 2020

    Breath Test, Oesophageal Cancer, Gastric Cancer Trial in London (Oral Stimulant Drink)

    Not yet recruiting
    • Breath Test
    • +4 more
    • Oral Stimulant Drink
    • London, United Kingdom
      Volatile Biomarker Group, Commonwealth Building, Hammersmith Hos
    Oct 30, 2022

    Volatile Organic Compounds, Microbiome, Microbioata Trial in London (Oral Stimulant Drink)

    Recruiting
    • Volatile Organic Compounds
    • +9 more
    • Oral Stimulant Drink
    • London, United Kingdom
      Imperial College NHS Foundation Trust
    Aug 16, 2022

    Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)

    Not yet recruiting
    • Esophageal Cancer
    • Gastric Cancer
    • Surveillance protocol
    • Cologne, Germany
    • +12 more
    Oct 29, 2023

    IMaC - Immune Pathways in Oesophagogastric Cancer

    Not yet recruiting
    • Oesophagogastric Cancer
    • No intervention sample collection only
    • Guildford, United Kingdom
    • +2 more
    Oct 4, 2023

    Cardiorespiratory Fitness and Lung Function in Lung Cancer

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Multimodal prehabilitation
    • (no location specified)
    Dec 2, 2022

    Oesophageal Cancer Trial in United Kingdom (Cytosponge™)

    Completed
    Has Results
    • Oesophageal Cancer
    • Cytosponge™
    • Bodelwyddan, United Kingdom
    • +10 more
    Mar 28, 2022

    Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

    Not yet recruiting
    • Gastric Adenocarcinoma
    • cadonilimab combined +paclitaxel (albumin-bound)
    • (no location specified)
    Nov 1, 2023

    Gastric Cancer Stage IV Trial in Wuhan (Toripalimab, Docetaxel, nab-paclitaxel)

    Recruiting
    • Gastric Cancer Stage IV
    • Wuhan, Hubei, China
      Cancer Center, Union Hospital, Tongji Medical College, Huazhong
    Mar 14, 2021

    Esophageal Anastomotic Leak, Tissue Pressure of Oxygen Trial in Valencia (Preoperative Arterial Embolization)

    Completed
    • Esophageal Anastomotic Leak
    • Tissue Pressure of Oxygen
    • Preoperative Arterial Embolization
    • Valencia, VAL, Spain
      Hospital Clínico Universitario de Valencia
    Jan 19, 2022

    Local and Peripheral Immune Responsive Landscape Induced by

    Not yet recruiting
    • Lung Adenocarcinoma
    • Local Cryoablation
      • (no location specified)
      Oct 24, 2023

      Upper Gastrointestinal Disorders Trial in Southampton (Cardiopulmonary exercise testing)

      Completed
      • Upper Gastrointestinal Disorders
      • Cardiopulmonary exercise testing
      • Southampton, United Kingdom
        University Hospitals Southampton
      Apr 5, 2022

      HER-2 Expression in Pancreatic Duct Adenocarcinoma

      Completed
      • Pancreatic Adenocarcinoma
      • immunohistochemical approach
      • (no location specified)
      Sep 20, 2023

      Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

      Not yet recruiting
      • Gastric
      • Colorectal Adenocarcinoma
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital & Institute
      Nov 1, 2023

      Tumor Size and Prognosis in Small Bowel adenocarcinoma-a

      Completed
      • Prognosis
      • no interventions
      • Dalian, Liaoning, China
        Dalian Third People's Hospital Affiliated to Dalian Medical Univ
      Oct 11, 2023

      Google Location History Following Oesophagectomy and/or

      Recruiting
      • Oesophageal Cancer
      • +3 more
      • Physical activity assessment
      • London, United Kingdom
        Imperial College London
      Mar 30, 2022

      Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

      Not yet recruiting
      • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
      • (no location specified)
      Jul 17, 2023

      Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

      Recruiting
      • Gastric Adenocarcinoma
      • Adenocarcinoma of Gastroesophageal Junction
      • Docetaxel for injection (Albumin-bound)
      • Taxotere
      • Guangzhou, China
        Ethics Committee of Sun-Yat-Sen University Cancer Center
      Jan 27, 2023

      HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

      Not yet recruiting
      • HER2-positive Advanced Gastric Cancer
      • HER2-positive Gastroesophageal Junction Adenocarcinoma
      • Trastuzumab deruxtecan
      • (no location specified)
      Aug 11, 2023

      Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

      Recruiting
      • Gastric Cancer
      • +3 more
      • Fruquintinib + SOX
      • Nanning, China
        Guangxi Medical University Cancer Hospital
      Dec 2, 2022

      Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

      Not yet recruiting
      • Adenocarcinoma - GEJ
      • Gastric Adenocarcinoma
      • (no location specified)
      Sep 26, 2023

      Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

      Active, not recruiting
      • Stomach Neoplasms
      • Shanghai, China
        Renji Hospital
      Apr 3, 2023